Benzoyl-L-alanine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Benzoyl-L-alanine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
L-Amino Acids
Catalog number
BAT-003888
CAS number
2198-64-3
Molecular Formula
C10H11NO3
Molecular Weight
193.20
Benzoyl-L-alanine
IUPAC Name
(2S)-2-benzamidopropanoic acid
Synonyms
Bz-L-Ala-OH
Appearance
White powder
Purity
≥ 99% (HPLC)
Density
1.224 g/cm3
Melting Point
138-140 °C
Boiling Point
148-151 °C
Storage
Store at 2-8 °C
InChI
InChI=1S/C10H11NO3/c1-7(10(13)14)11-9(12)8-5-3-2-4-6-8/h2-7H,1H3,(H,11,12)(H,13,14)/t7-/m0/s1
InChI Key
UAQVHNZEONHPQG-ZETCQYMHSA-N
Canonical SMILES
CC(C(=O)O)NC(=O)C1=CC=CC=C1

Benzoyl-L-alanine, a versatile chemical compound, finds diverse applications in biochemical, pharmaceutical research, and industrial processes. Here are the key applications of Benzoyl-L-alanine, explored with a high degree of perplexity and burstiness:

Drug Development: Serving as a pivotal intermediate in pharmaceutical synthesis, Benzoyl-L-alanine plays a crucial role in crafting compounds with potent antimicrobial and anti-inflammatory properties. Researchers leverage this compound as a cornerstone for building drugs that exhibit enhanced biological activity and refined pharmacokinetic profiles, paving the way for innovative pharmaceutical solutions.

Protein Modification: Within the realm of biochemical investigations, Benzoyl-L-alanine emerges as a potent tool for protein and peptide modification. By integrating this compound into protein structures, scientists delve into the intricacies of protein folding, stability, and interactions, unraveling crucial insights into protein function. This modification lays the foundation for novel protein-based therapeutics, heralding a new era in precision medicine.

Chiral Synthesis: At the forefront of asymmetric synthesis, Benzoyl-L-alanine emerges as a key player in generating chiral compounds with exceptional enantiomeric purity. These compounds form the backbone of pharmaceutical agent production, often displaying superior efficacy and reduced side effects compared to racemic mixtures. Through Benzoyl-L-alanine's assistance, chemists forge efficient synthetic pathways for these invaluable enantiomers, driving innovation in drug design and development.

Analytical Chemistry: Embraced as a standard and reagent in analytical chemistry, Benzoyl-L-alanine assumes a pivotal role in diverse assays. Its presence in chromatographic techniques facilitates the separation and identification of various amino acids and peptides, underpinning quality control in biochemical product manufacturing. This application stands as a cornerstone in proteomics and metabolomics research, ensuring precision and consistency in biochemical analyses.

1. Kinetic anomalies in chymotryptic hydrolyses of p-nitrophenyl acetate and N-benzoyl-L-alanine methyl ester
D Nohara, M Wakamatsu, M Goto, T Sakai Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1685-90. doi: 10.1248/cpb.37.1685.
Kinetic and thermodynamic parameters were evaluated for the acylation and the deacylation steps in the hydrolysis of p-nitrophenyl acetate by alpha-chymotrypsin at pH 7.8 and at temperatures between 15 and 35 degrees C by the use of stopped-flow and ordinary ultraviolet spectrophotometers. In contrast to the temperature dependencies of k2 and Ks reported in the literature (P.A. Adams and E.R. Swart, Biochem. J., 161, 83 (1977], no kinetic anomaly was observed in either of the steps, but reasonable straight lines were obtained in both Arrhenius and van't Hoff plots. On the other hand, in the chymotryptic hydrolysis of N-benzoyl-L-alanine methyl ester a sharp kinetic anomaly was found. The discrepancy in the case of p-nitrophenyl acetate is discussed in connection with a possible conformational change of the enzyme, an alteration of the rate-limiting step or differences in the experimental procedures. The cause of the anomaly observed in the case of N-benzoyl-L-alanine methyl ester is also discussed in detail.
2. Reaction of Pseudomonas fluorescens kynureninase with beta-benzoyl-L-alanine: detection of a new reaction intermediate and a change in rate-determining step
Vijay B Gawandi, Diane Liskey, Santiago Lima, Robert S Phillips Biochemistry. 2004 Mar 23;43(11):3230-7. doi: 10.1021/bi036043k.
Beta-benzoyl-DL-alanine was synthesized from alpha-bromoacetophenone and diethyl acetamidomalonate. The racemic amino acid was resolved by carboxypeptidase A-catalyzed hydrolysis of the N-trifluoroacetyl derivative. Beta-benzoyl-L-alanine is a good substrate of kynureninase from Pseudomonas fluorescens, with k(cat) and k(cat)/K(m) values of 0.7 s(-1) and 8.0 x 10(4) M(-1) s(-1), respectively, compared to k(cat) = 16.0 s(-1) and k(cat)/K(m) = 6.0 x 10(5) M(-1) s(-1) for L-kynurenine. In contrast to the reaction of L-kynurenine, beta-benzoyl-L-alanine does not exhibit a significant solvent isotope effect on k(cat) ((H)k/(D)k = 0.96 +/- 0.06). The pre-steady-state kinetics of the reaction of beta-benzoyl-L-alanine were investigated by rapid scanning stopped-flow spectrophotometry. The spectra show the formation of a quinonoid intermediate, with lambda(max) = 490 nm, in the dead time of the instrument, which then decays, with k = 210 s(-1), to form a transient intermediate with lambda(max) at 348 nm. In the presence of benzaldehyde, the 348 nm intermediate decays, with k = 0.7 s(-1), to form a quasistable quinonoid species with lambda(max) = 492 nm. Previous studies demonstrated that benzaldehyde can trap an enamine intermediate formed after the C(beta)-C(gamma) bond cleavage [Phillips, R. S., Sundararaju, B., and Koushik, S. V. (1998) Biochemistry 37, 8783-8789]. Thus, the 348 nm intermediate is kinetically competent. The position of the absorption maximum and shape of the band is consistent with a PMP-ketimine intermediate. The results from chemical quenching analysis do not show a burst of benzoate and, thus, also support the formation of benzoate as the rate-determining step. These data suggest that, in contrast to L-kynurenine, for which the rate-determining step was shown to be deprotonation of the pyruvate-ketimine intermediate [Koushik, S. V., Moore, J. A., III, Sundararaju, B., and Phillips, R. S. (1998) Biochemistry 37, 1376-1382], the rate-determining step in the reaction of beta-benzoyl-L-alanine with kynureninase is C(beta)-C(gamma) bond cleavage.
3. FT-IR and Raman spectroscopic and DFT studies of anti-cancer active molecule N-{(meta-ferrocenyl) Benzoyl} - l-alanine - glycine ethyl ester
T S Xavier, Peter T M Kenny, D Manimaran, I Hubert Joe Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jun 15;145:523-530. doi: 10.1016/j.saa.2015.02.087. Epub 2015 Mar 10.
FT-Raman and FT-IR spectra of N-{(meta-ferrocenyl) Benzoyl} - l-alanine - glycine ethyl ester were recorded in solid phase. The optimized molecular geometry, the vibrational wavenumbers, the infrared intensities and the Raman scattering intensities were calculated by using density functional method(B3LYP) with 6-31G(d, p) basis set. Vibrational assignment of the molecule was done by using potential energy distribution analysis. Natural bond orbital analysis, Mulliken charge analysis and HOMO-LUMO energy were used to elucidate the reasons for intra molecular charge transfer. Docking studies were conducted to predict its anticancer activity.
Online Inquiry
Verification code
Inquiry Basket